- Home
- BMI vs LEGN Comparison
BMI vs LEGN Comparison
Compare BMI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMI
- LEGN
- Stock Information
- Founded
- BMI 1905
- LEGN 2014
- Country
- BMI United States
- LEGN United States
- Employees
- BMI N/A
- LEGN N/A
- Industry
- BMI Industrial Machinery/Components
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- BMI Industrials
- LEGN Health Care
- Exchange
- BMI Nasdaq
- LEGN Nasdaq
- Market Cap
- BMI 5.6B
- LEGN 7.0B
- IPO Year
- BMI N/A
- LEGN 2020
- Fundamental
- Price
- BMI $190.10
- LEGN $33.93
- Analyst Decision
- BMI Buy
- LEGN Strong Buy
- Analyst Count
- BMI 7
- LEGN 12
- Target Price
- BMI $226.83
- LEGN $79.00
- AVG Volume (30 Days)
- BMI 277.4K
- LEGN 1.1M
- Earning Date
- BMI 04-17-2025
- LEGN 03-11-2025
- Dividend Yield
- BMI 0.71%
- LEGN N/A
- EPS Growth
- BMI 34.71
- LEGN N/A
- EPS
- BMI 4.23
- LEGN N/A
- Revenue
- BMI $826,558,000.00
- LEGN $627,241,000.00
- Revenue This Year
- BMI $13.28
- LEGN $66.76
- Revenue Next Year
- BMI $8.19
- LEGN $51.82
- P/E Ratio
- BMI $44.97
- LEGN N/A
- Revenue Growth
- BMI 17.48
- LEGN 119.97
- 52 Week Low
- BMI $151.18
- LEGN $30.17
- 52 Week High
- BMI $239.11
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- BMI 35.88
- LEGN 39.62
- Support Level
- BMI $187.13
- LEGN $34.00
- Resistance Level
- BMI $197.36
- LEGN $36.20
- Average True Range (ATR)
- BMI 5.57
- LEGN 1.39
- MACD
- BMI -0.53
- LEGN -0.33
- Stochastic Oscillator
- BMI 13.36
- LEGN 18.23
About BMI Badger Meter Inc.
Badger Meter Inc is an innovator, manufacturer, and marketer of products incorporating flow measurement, quality, control, and other system solutions serving markets. The company's products measure water, oil, chemicals, and other fluids, and provide and communicate timely measurement data. Its product lines include two categories: sales of water meters, radios, software, and related technologies, and water quality monitoring solutions to water utilities (utility water) and sales of meters and other sensing instruments, valves, software, and other solutions for industrial applications in water, wastewater, and other industries (flow instrumentation). It derives a majority of its revenues from the United States.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.